莫亚莫亚病患者的治疗选择:回顾性队列研究
Yuting Luo1,2,3, Chutong Guo1,2,3, Shaoqing Wu4
1Department of Neurology, The First Affiliated Hospital, Sun Yat-sen University, 510080 Guangzhou, Guangdong, China.
Revista de neurologia
|January 8, 2026
概括
年龄较小,已婚,没有高脂血症是影响莫亚莫亚病 (MMD) 患者选择手术重血管化的关键因素. 这尤其适用于无症状的MMD病例.
科学领域:
- 神经外科 神经外科
- 神经学 神经学
- 血管外科 血管外科
背景情况:
- 莫亚莫亚病 (MMD) 是一种罕见的脑血管疾病.
- 手术复血管化是标准的治疗方法,但非手术治疗是常见的.
- 在MMD患者的治疗决策需要了解影响因素.
研究的目的:
- 确定影响莫亚莫亚病患者治疗选择的因素.
- 专门分析无症状MMD病例的治疗偏好.
主要方法:
- 对147名莫亚莫亚病患者 (2010-2022) 的回顾性分析.
- 使用统计测试对基线特征进行比较.
- 多变量逻辑回归用于确定与治疗选择相关的因素.
主要成果:
- 62.6%的患者接受了手术治疗.
- 年龄较小,婚姻状况较低,缺乏高脂血症预测了手术选择.
- 无症状MMD患者的手术率 (67.9%) 比症状患者 (59.6%) 高.
结论:
- 年龄较小是莫亚莫亚病手术治疗的重要预测因素.
- 治疗决策,即使在无症状的MMD中,也受到患者人口统计学和并发症的影响.
相关概念视频
Mitral Stenosis III: Medical Management
239
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
239
Aneurysm II: Clinical Manifestations and Diagnostic Studies
273
Thoracic, aortic arch and abdominal aneurysms are significant vascular conditions that can present with various clinical manifestations and lead to serious complications. Understanding these manifestations and the appropriate diagnostic studies is essential for effective management and treatment.Thoracic Aortic AneurysmsThoracic aortic aneurysms often remain asymptomatic until they reach a size that impinges on adjacent structures. They typically cause deep, diffuse chest pain that radiates to...
273
Atherosclerosis III: Management
312
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
312
Mitral Regurgitation III: Medical Management
268
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
268
Ischemic Heart Disease: Overview
2.8K
Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
2.8K
Mitral Stenosis II: Clinical features and Diagnostic Tests
213
Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
213


